Johann de Jong obtained his PhD in Computational Cancer Biology from Delft University of Technology. Since then, he has gained experience in a wide variety of domains, ranging from gene regulation and chromatin biology to cancer research and neurological disorders, in both academia (the Netherlands Cancer Institute) and industry (BASF, UCB). He currently works as a Principal Scientist at UCB, and develops and applies methods grounded in machine learning (including deep learning) and statistics for the analysis of biological and clinical datasets, within the context of precision medicine.